Emergent BioSolutions Inc. (EBS)

NYSE: EBS · Real-Time Price · USD

7.26

-0.24 (-3.20%)

At close: Jul 24, 2026, 4:00 PM EDT

7.21

-0.05 (-0.69%)

After-hours: Jul 24, 2026, 7:34 PM EDT

Emergent BioSolutions Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	676.8	742.9	1,044	1,049	1,118	1,774
Revenue Growth	-29.89%	-28.81%	-0.54%	-6.10%	-36.99%	12.45%
Gross Profit	367.1	416.7	362.3	343.9	424.4	1,026
Operating Income	60.7	100.1	-108.7	-726.4	-170	341.4
Net Income	-8.6	52.6	-190.6	-760.5	-211.6	219.5
Earnings Per Share	-0.28	0.93	-3.60	-14.85	-4.22	4.06
EPS Growth	-	-	-	-	-	-28.52%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Commercial Products	223.7	226.1	398.9	497.3	386.6	438
Mcm Products	401.9	456.7	509.8	447.2	579.6	585.9
Other	51.2	60.1	134.9	104.8	-	-
Total	676.8	742.9	1,044	1,049	1,118	1,774

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	160.3	205.4	99.5	111.7	642.6	576.1
Total Debt	573.6	572.1	663.7	1,274	2,363	872.6
Net Cash (Debt)	-413.3	-366.7	-564.2	-1,162	-1,721	-296.5
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-7.53	-6.47	-10.65	-22.70	-34.34	-5.48

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	148	170.6	58.7	-206.3	-34.1	320.2
Capital Expenditures	-12.6	-13.8	-22.9	-51.6	-115.8	-224.1
Free Cash Flow	135.4	156.8	35.8	-257.9	-149.9	96.1
Free Cash Flow Growth	43.43%	337.99%	-	-	-	-75.67%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	54.24%	56.09%	34.72%	32.77%	37.98%	57.82%
Operating Margin	8.97%	13.47%	-10.42%	-69.23%	-15.21%	19.25%
Pretax Margin	0.52%	11.15%	-13.69%	-69.68%	-19.60%	17.10%
Profit Margin	-1.27%	7.08%	-18.26%	-72.48%	-18.94%	12.38%
FCF Margin	20.01%	21.11%	3.43%	-24.58%	-13.41%	5.42%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	13.29	-	-	-	10.71
Forward PE	-	4.16	12.57	20.50	51.15	7.19
P/FCF Ratio	2.77	4.11	14.47	-	-	23.21
PS Ratio	0.55	0.87	0.50	0.12	0.53	1.26